Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: intranasal delivery

October 2, 2024 Drug delivery / Pharma applications

An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting

The surge in neurological disorders necessitates innovative strategies for delivering active pharmaceutical ingredients to the brain. The non-invasive intranasal route

Continue reading

April 18, 2022 Drug delivery / Pharma applications

Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs

Intranasal administration is a promising route for brain drug delivery. However, it can be difficult to formulate drugs that have

Continue reading

October 12, 2021 CD as API / Drug delivery / Pharma applications

Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?

The use of CDs in nasal formulations allowed obtaining versatile drug delivery systems intended for local and systemic effects, as

Continue reading

November 18, 2020 CD as API / CD derivatives / Pharma applications

Oxidized CD bisulfite against influenza A virus

Previous reports have demonstrated that compounds based on sulfo derivatives of oligo- and polysaccharides possess high antiviral activity. In this

Continue reading

Recent Posts

  • Enhancing Emulsifying Properties of HPBCD with octenyl succinic anhydride
  • CD-functionalized chitosan hydrogels for pH-responsive drug delivery
  • Handbook of Cyclodextrin-Based Enabling Technologies for Overcoming the Solubility and Bioavailability Limitations of Class II, III and IV Drugs
  • Call for Chapters: Cyclodextrins for Next-Generation Electronics and Energy Storage
  • Call for Chapters: Cyclodextrins in Nutraceuticals 

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (71)
  • CD as API (348)
  • CD derivatives (419)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (799)
  • E-ducation (63)
  • Environmental (138)
  • Events (234)
  • Food (226)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (404)
  • Other industrial use (109)
  • Pharma applications (1,192)
  • Supramolecular systems (42)
  • Uncategorized (154)

Top Posts

  • Enhancing Emulsifying Properties of HPBCD with octenyl succinic anhydride
  • 19th International Symposium on Macrocyclic and Supramolecular Chemistry 2025
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • Trans sodium crocetinate/cyclodextrin to increase diffusion of oxygen
  • Cyclodextrins Across the Eye-Care Spectrum
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Solventless Crosslinking of Chitosan, Xanthan, and Locust Bean Gum Networks Functionalized with β-Cyclodextrin
  • PEG-β-Cyclodextrin polymer-based formulation to increase the antiangiogenic activity of rutin in vivo
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Characterization of the substitution pattern of 2-hydroxypropyl-β-cyclodextrin using NMR spectroscopy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...